2026 medical update on MSC therapy for diabetic foot ulcers: M2 macrophage polarization, EXO-miR3671 angiogenesis, hydrogel delivery, UC-MSC vs ADSC head-to-head, 47-RCT meta-analysis, and cost-effectiveness vs amputation in Thailand.
Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026, who qualifies, and what options exist in Thailand now.
Diabetic wounds that refuse to heal affect hundreds of thousands of Thais. Discover how exosome therapy and MSC treatment are giving patients a real path to recovery.
Diabetes affects millions across Thailand. Can stem cell therapy help reverse it? Our Bangkok clinic shares real patient outcomes, THB pricing, and what the latest research says about stem cells for diabetes in 2026.
Type 1 diabetes has long been considered a lifelong condition, requiring constant management and insulin therapy. However, recent developments in stem cell research are challenging this notion and offering hope for a potential cure. This article explores the groundbreaking study by Vertex Pharmaceuticals that’s making waves in the diabetes community...
In a landmark development for stem cell research and diabetes treatment, Vertex Pharmaceuticals has achieved remarkable success with their investigational therapy VX-880 for type 1 diabetes (T1D). This breakthrough, based on longstanding research from Harvard Stem Cell Institute’s Melton Lab, represents one of the first practical applications of embryonic stem...
科学家们正在开发一种有前途的治疗 1 型糖尿病的方法，方法是使用干细胞来制造可以替代无功能胰腺细胞的胰岛素生成细胞（称为 β 细胞）。 （更多…）
2 型糖尿病患者的肌肉功能往往比其他人差。现在，一个研究小组发现，在 2 型糖尿病中，一个特定的基因对于肌肉干细胞产生新的成熟肌肉细胞的能力非常重要。 （更多…）
Chinese 
English 
Russian 
French